Furthermore, miR-125b, which trends higher in both AD brain and in ROS-treated HN cells, is predicted to target the mRNA of synapsin I and synapsin II, and thus downregulation of synapsins in AD may be partially explained by miR-125b upregulation [101,102]. Here, SYN1 is linked to Alzheimer disease.